Pharmacotherapies for cannabis dependence DOI

Kushani Marshall,

Linda Gowing, Robert Ali

et al.

Cochrane library, Journal Year: 2014, Volume and Issue: unknown

Published: Dec. 17, 2014

Language: Английский

Marijuana Legalization: Impact on Physicians and Public Health DOI Open Access
Samuel T. Wilkinson,

Stephanie Yarnell,

Rajiv Radhakrishnan

et al.

Annual Review of Medicine, Journal Year: 2015, Volume and Issue: 67(1), P. 453 - 466

Published: Oct. 30, 2015

Marijuana is becoming legal in an increasing number of states for both medical and recreational use. Considerable controversy exists regarding the public health impact these changes. The evidence legitimate use marijuana or cannabinoids limited to a few indications, notably HIV/AIDS cachexia, nausea/vomiting related chemotherapy, neuropathic pain, spasticity multiple sclerosis. Although show therapeutic promise other areas, robust clinical still lacking. relationship between legalization prevalence unknown. where have higher rates than nonlegal states, were generally found even prior legalization. As continue proceed with use, certain issues become increasingly relevant, including effects acute intoxication on driving abilities, unintentional ingestion products by children, opioid whether there will be increase problems such as dependence/addiction, psychosis, pulmonary disorders. In light this rapidly shifting landscape, more research urgently needed better understand health.

Language: Английский

Citations

180

Verbal learning and memory in adolescent cannabis users, alcohol users and non-users DOI
Nadia Solowij, Katy A. Jones,

Megan Rozman

et al.

Psychopharmacology, Journal Year: 2011, Volume and Issue: 216(1), P. 131 - 144

Published: Feb. 16, 2011

Language: Английский

Citations

212

Cognitive mechanisms underlying risky decision-making in chronic cannabis users DOI
Daniel J. Fridberg,

Sarah Queller,

Woo‐Young Ahn

et al.

Journal of Mathematical Psychology, Journal Year: 2009, Volume and Issue: 54(1), P. 28 - 38

Published: Dec. 3, 2009

Language: Английский

Citations

172

Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective DOI Creative Commons
Koby Cohen, Aviv Weinstein

Frontiers in Public Health, Journal Year: 2018, Volume and Issue: 6

Published: June 7, 2018

There is a growing use of novel psychoactive drugs (NPs) containing synthetic cannabinoids. Synthetic cannabinoid products have similar effects to those natural cannabis, yet, these are more potent and dangerous, they been associated with various adverse effects. Here, we review current literature on the epidemiology, acute, chronic based drugs. contain mixture compounds that most them bind receptors high potency. These mimic cannabis Δ9-tetrahydrocannabinol (THC) but induce severe including respiratory difficulties, hypertension, tachycardia, chest pain, muscle twitches, acute renal failure, anxiety, agitation, psychosis, suicidal ideation, cognitive impairment. Chronic cannabinoids was serious psychiatric medical conditions even death. Given popularity in their harmful potential, there need for further research this field.

Language: Английский

Citations

156

Pharmacotherapies for cannabis dependence DOI

Kushani Marshall,

Linda Gowing, Robert Ali

et al.

Cochrane library, Journal Year: 2014, Volume and Issue: unknown

Published: Dec. 17, 2014

Language: Английский

Citations

152